Stem Cells and Disease Modelling

Human pluripotent stem cells (HPSCs) are useful model system for understanding the genetic basis of human cardiovascular diseases. HPSCs are often firmly genetically matched to patients with disease. Previously, only in unusual substance was it viable to review primary tissues like heart muscle and blood vessels obtained directly from living patients, and even in such circumstances, the quantity of tissue was limited. HPSCs produce a replacement approach that gives a unique opportunity to review human cells that are matched to the patients of interest. Because they will be propagated into very large numbers and differentiated into a spread of cell types that are relevant to cardiovascular diseases—including cardio myocytes, vascular endothelial and smooth muscle cells, and hepatocytes—HPSCs can in theory provide a limitless source of fabric with which to dissect the molecular support of the patient’s disease process within and beyond the circulatory system.

    Related Conference of Stem Cells and Disease Modelling

    April 16-17, 2026

    19th World Congress on Stem Cell Research

    Tokyo, Japan
    June 08-09, 2026

    9th Global Conference on Cell and Gene Therapy

    Rome, Italy
    June 15-16, 2026

    22nd Global Summit on Stem Cell & Regenerative Medicine

    Amsterdam, Netherlands
    June 15-16, 2026

    13th World Congress on Epigenetics and Chromosome

    Paris, France
    June 18-19, 2026

    19th International Conference on Genomics & Pharmacogenomics

    Singapore City, Singapore
    September 25-26, 2025

    6th Annual summit on Cell Signaling and Cancer Therapy

    Montreal, Canada

    Stem Cells and Disease Modelling Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in